Hypofractionated radiotherapy for poor prognosis malignant glioma: Matched pair survival analysis with MRC controls

Radiotherapy and Oncology

Volumn 67, Issue 2, 2003, Pages 177-182

  McAleese, J J ^a   Stenning, S P ^b   Ashley, S ^a   Traish, D ^a   Hines, F ^a   Sardell, S ^a   Guerrero, D ^a   Brada, Michael ^a,c  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

High grade glioma; Palliation; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FRACTIONATION; GLIOBLASTOMA; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SCORING SYSTEM; SURVIVAL RATE; WORLD HEALTH ORGANIZATION;

EID: 0037838840     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(03)00077-X     Document Type: Article

References (21)

1. Bauman G.S., Gaspar L.E., Fisher B.J., et al. A prospective study of short course radiotherapy in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 29:1994;835-839.
2. Chang C.H., Horton J., Schoenfeld D., et al. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer. 52:(6):1983;997-1007.
3. Curran W.J., Scott C.B., Horton J., et al. Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant giloma trials. J Natl Cancer Inst. 85:1993;704-710.
4. Davies E., Clarke C., Hopkins A. Malignant cerebral glioma: survival, disability, and morbidity after radiotherapy. Br Med J. 313:1996;1507-1512.
5. Faithfull S., Brada M. Somnolence syndrome in adults following cranial irradiation for primary brain tumours. Clin Oncol. 10:1998;250-254.
6. Ford J.M., Stenning S.P., Boote D.J., et al. A short fractionation radiotherapy treatment for poor prognosis patients with high grade glioma. Clin Oncol. 9:(1):1997;20-24.
7. Gresham G., Philips T., Labi M. ADL status in stroke, relative merits of three standard indexes. Arch Phys Med Rehabil. 61:1980;355-358.
8. Kleinberg L., Slick T., Enger C., et al. Short course radiotherapy is an appropriate option for most malignant glioma patients. Int J Radiat Oncol Biol Phys. 38:(1):1997;31-36.
9. Kristiansen K., Hagen S., Kollevold T., et al. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer. 47:(4):1981;649-652.
10. Prognostic factors for high grade malignant glioma: development of a prognostic index. J Neurooncol. 9:1990;47-55.
11. A medical research council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. Br J Cancer. 64:(4):1991;769-774.
12. Murdoch C. A critical review of the Barthel index. Br J Occup Ther. 55:(3):1992;109-111.
13. Sandberg W.M., Malmström P., Strömblad L.G., et al. A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4. Cancer. 68:1991;22-29.
14. Scott C.B. Quality-adjusted survival analysis of malignant glioma patients. Control Clin Trials. 18:(4):1997;277-285.
15. Scott C.B., Scarantino C., Urtasun R., et al. Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radiat Oncol Biol Phys. 40:(1):1998;51-55.
16. Slotman B.J., Kralendonk J.H., van Alphen H.A., Kamphorst W., Karim A.B. Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors. Int J Radiat Oncol Biol Phys. 34:(4):1996;895-898.
17. Thomas R., James N., Guerrero D., et al. Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma. Radiother Oncol. 33:(2):1994;113-116.
18. Thomas R., Guerrero D., Hines F., Ashley S., Brada M. Modifying the Barthel performance index score for use in patients with brain tumours [published erratum appears in Eur J Cancer Care (Engl), 6(3) (1997) 173]. Eur J Cancer Care (Engl). 4:(2):1995;63-68.
19. Thomas D., Brada M., Stenning S. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial. J Clin Oncol. 19:(2):2001;509-518.
20. Walker M.D., Alexander E. Jr, Hunt W.E., et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg. 49:(3):1978;333-343.
21. Walker M.D., Strike T.A., Sheline G.E. An analysis of dose effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys. 5:1979;1725.